Ausgabe 5/2015
Inhalt (7 Artikel)
NF-κB signaling in cancer stem cells: a promising therapeutic target?
K. Vazquez-Santillan, J. Melendez-Zajgla, L. Jimenez-Hernandez, G. Martínez-Ruiz, V. Maldonado
MYCN concurrence with SAHA-induced cell death in human neuroblastoma cells
Constanza Cortés, Sara C. Kozma, Albert Tauler, Santiago Ambrosio
Anti-tumor effect of emodin on gynecological cancer cells
Yaoxian Wang, Hui Yu, Jin Zhang, Xin Ge, Jing Gao, Yunyan Zhang, Ge Lou
Metformin and epithelial ovarian cancer therapeutics
Seema Patel, Lalit Kumar, Neeta Singh
Manipulation of tumor metabolism for therapeutic approaches: ovarian cancer-derived cell lines as a model system
Kristina Goetze, Christian G. Fabian, Andrea Siebers, Livia Binz, Daniel Faber, Stefano Indraccolo, Giorgia Nardo, Ulrike G. A. Sattler, Wolfgang Mueller-Klieser
Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients
Ana Koren, Eva Sodja, Matija Rijavec, Mojca Jez, Viljem Kovac, Peter Korosec, Tanja Cufer
Methylation biomarkers for pleomorphic lobular breast cancer - a short report
Cathy B. Moelans, Eva J. Vlug, Cigdem Ercan, Peter Bult, Horst Buerger, Gabor Cserni, Paul J. van Diest, Patrick W. B. Derksen